Company news
Synbio International Inc. news in 2026
Synbio International Inc.'s news releases, calls and decks from 2026, newest first.
Synbio (OTC: SYIN) Outlines a Two-Engine Healthcare Growth Strategy Combining Nutraceuticals and AI-Powered Mental Health Screening
October 1, 2026
Synbio International Signs Exclusive Licensing Agreement for Proprietary Nutraceutical Products, Accelerating Path to Revenue
September 8, 2026
Synbio International Commences Revenue-Generating Operations With Launch of Healing Forceâ„¢ Nutraceutical Division
August 11, 2026
Synbio International Secures DWAC and DRS Eligibility
April 8, 2026
Synbio Signs Agreement for a Proof-of-Concept Clinical Trial to Evaluate a Unique AI-Based Facial Analysis Screening Software for Mental Health Disorders
January 15, 2026